Growth Metrics

Gossamer Bio (GOSS) Cash from Investing Activities (2022 - 2025)

Gossamer Bio's Cash from Investing Activities history spans 4 years, with the latest figure at $73.2 million for Q4 2025.

  • For Q4 2025, Cash from Investing Activities rose 37.47% year-over-year to $73.2 million; the TTM value through Dec 2025 reached $156.4 million, up 438.74%, while the annual FY2025 figure was $156.4 million, 438.74% up from the prior year.
  • Cash from Investing Activities reached $73.2 million in Q4 2025 per GOSS's latest filing, up from $17.0 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $73.2 million in Q4 2025 to a low of -$118.3 million in Q3 2023.
  • Average Cash from Investing Activities over 4 years is $4.6 million, with a median of $8.6 million recorded in 2022.
  • The largest YoY upside for Cash from Investing Activities was 607.1% in 2024 against a maximum downside of 556.96% in 2024.
  • A 4-year view of Cash from Investing Activities shows it stood at $8.5 million in 2022, then tumbled by 269.73% to -$14.4 million in 2023, then skyrocketed by 470.43% to $53.2 million in 2024, then skyrocketed by 37.47% to $73.2 million in 2025.
  • Per Business Quant, the three most recent readings for GOSS's Cash from Investing Activities are $73.2 million (Q4 2025), $17.0 million (Q3 2025), and $44.1 million (Q2 2025).